• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非霍奇金淋巴瘤细胞系的分子细胞遗传学特征

Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.

作者信息

Mehra Sukvarsha, Messner Hans, Minden Mark, Chaganti R S K

机构信息

Laboratory of Cancer Genetics, Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Genes Chromosomes Cancer. 2002 Mar;33(3):225-34. doi: 10.1002/gcc.10025.

DOI:10.1002/gcc.10025
PMID:11807979
Abstract

Spectral karyotyping (SKY) and comparative genomic hybridization (CGH) have greatly enhanced the resolution of cytogenetic analysis, enabling the identification of novel regions of rearrangement and amplification in tumor cells. Here we report the analysis of 10 malignant non-Hodgkin lymphoma (NHL) cell lines derived at the Ontario Cancer Institute (OCI), Toronto, designated as OCI-Ly1, OCI-Ly2, OCI-Ly3, OCI-LY4, OCI-Ly7, OCI-Ly8, OCI-Ly12, OCI-Ly13.2, OCI-Ly17, and OCI-Ly18, by G-banding, SKY, and CGH, and we present their comprehensive cytogenetic profiles. In contrast to the 52 breakpoints identified by G-banding, SKY identified 87 breakpoints, which clustered at 1q21, 7p15, 8p11, 13q21, 13q32, 14q32, 17q11, and 18q21. G-banding identified 10 translocations, including the previously described recurring translocations, t(8;14)(q24;q32) and t(14;18)(q32;q21). In contrast, SKY identified 60 translocations, including five that were recurring, t(8;14)(q24;q32), t(14;18)(q32;q21), t(4;7)(p12;q22), t(11;18)(q22;q21), and t(3;18)(q21;p11). SKY also identified the source of all the marker chromosomes. In addition, 10 chromosomes that were classified as normal by G-banding were found by SKY to be rearranged. CGH identified seven sites of high-level DNA amplification, 1q31-32, 2p12-16, 8q24, 11q23-25, 13q21-22, 13q32-34, and 18q21-23; of these, 1q31-32, 11q23-25, 13q21-22, and 13q32-34 have previously not been described as amplified in NHL. This comprehensive cytogenetic characterization of 10 NHL cell lines identified novel sites of rearrangement and amplification; it also enhances their value in experimental studies aimed at gene discovery and gene function.

摘要

光谱核型分析(SKY)和比较基因组杂交(CGH)极大地提高了细胞遗传学分析的分辨率,能够识别肿瘤细胞中重排和扩增的新区域。在此,我们报告了对10株源自多伦多安大略癌症研究所(OCI)的恶性非霍奇金淋巴瘤(NHL)细胞系的分析,这些细胞系分别命名为OCI-Ly1、OCI-Ly2、OCI-Ly3、OCI-LY4、OCI-Ly7、OCI-Ly8、OCI-Ly12、OCI-Ly13.2、OCI-Ly17和OCI-Ly18,采用G显带、SKY和CGH技术进行分析,并展示了它们全面的细胞遗传学图谱。与G显带识别出的52个断点相比,SKY识别出87个断点,这些断点聚集在1q21、7p15、8p11、13q21、13q32、14q32、17q11和18q21。G显带识别出10种易位,包括先前描述的常见易位t(8;14)(q24;q32)和t(14;18)(q32;q21)。相比之下,SKY识别出60种易位,包括5种常见易位,即t(8;14)(q24;q32)、t(14;18)(q32;q21)、t(4;7)(p12;q22)、t(11;18)(q22;q21)和t(3;18)(q21;p11)。SKY还识别出所有标记染色体的来源。此外,SKY发现10条被G显带分类为正常的染色体发生了重排。CGH识别出7个高水平DNA扩增位点,分别为1q31-32、2p12-16、8q24、11q23-25、13q21-22、13q32-34和18q21-23;其中,1q31-32、11q23-25、13q21-22和13q32-34此前未被描述为在NHL中发生扩增。这10株NHL细胞系的全面细胞遗传学特征识别出了重排和扩增的新位点;同时也提高了它们在旨在基因发现和基因功能研究的实验中的价值。

相似文献

1
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.非霍奇金淋巴瘤细胞系的分子细胞遗传学特征
Genes Chromosomes Cancer. 2002 Mar;33(3):225-34. doi: 10.1002/gcc.10025.
2
Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.光谱核型分析可识别弥漫性大B细胞淋巴瘤中的新重排、易位及临床关联。
Blood. 2002 Apr 1;99(7):2554-61. doi: 10.1182/blood.v99.7.2554.
3
Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.滤泡性淋巴瘤(FL)的分子细胞遗传学分析提供了与t(14;18)(q32;q21)阳性和阴性亚群及组织学进展相关的染色体不稳定性的详细特征。
Cytogenet Genome Res. 2007;118(2-4):337-44. doi: 10.1159/000108318.
4
Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.宫颈癌细胞系的全面分子细胞遗传学特征分析
Genes Chromosomes Cancer. 2003 Mar;36(3):233-41. doi: 10.1002/gcc.10158.
5
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.对一组伯基特淋巴瘤来源的B细胞系进行联合光谱核型分析、比较基因组杂交和体外凋亡分析,揭示了染色体畸变的意外复杂性以及化疗耐药细胞系中特定异常的复发情况。
Int J Oncol. 2006 Mar;28(3):605-17.
6
Unusual karyotype aberrations involving 2p12, 3q27, 18q21, 8q24, and 14q32 in a patient with non-Hodgkin lymphoma/acute lymphoblastic leukemia.一名非霍奇金淋巴瘤/急性淋巴细胞白血病患者存在涉及2p12、3q27、18q21、8q24和14q32的异常核型畸变。
Cancer Genet Cytogenet. 2003 Apr 1;142(1):60-4. doi: 10.1016/s0165-4608(02)00801-4.
7
Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.对363例连续确诊的弥漫性大B细胞淋巴瘤进行细胞遗传学分析。
Genes Chromosomes Cancer. 1999 Jun;25(2):123-33.
8
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.434例连续确诊的非霍奇金淋巴瘤标本的细胞遗传学分析:复发性染色体畸变、组织学与细胞毒性治疗暴露之间的相关性
Genes Chromosomes Cancer. 1991 May;3(3):189-201. doi: 10.1002/gcc.2870030304.
9
Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations.147例非霍奇金淋巴瘤的细胞遗传学分析:非随机染色体异常与组织学相关性
Br J Haematol. 1990 Oct;76(2):231-7. doi: 10.1111/j.1365-2141.1990.tb07877.x.
10
Multicolor spectral karyotyping of serous ovarian adenocarcinoma.
Genes Chromosomes Cancer. 2002 Feb;33(2):123-32. doi: 10.1002/gcc.1221.

引用本文的文献

1
The mitotic STAG3-cohesin complex shapes male germline nucleome.有丝分裂期的STAG3-黏连蛋白复合体塑造雄性生殖系核组。
Nat Struct Mol Biol. 2025 Aug 25. doi: 10.1038/s41594-025-01647-w.
2
Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach.弥漫性大B细胞淋巴瘤(DLBCL)中自噬的分析揭示了亚型特异性差异,并且在生发中心B细胞样弥漫性大B细胞淋巴瘤(GCB-DLBCL)中对ULK1抑制的优先靶向提供了一种作为新治疗方法的理论依据。
Leukemia. 2024 Feb;38(2):424-429. doi: 10.1038/s41375-024-02147-4. Epub 2024 Jan 23.
3
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
一种新型三作用抑制剂靶向 B 细胞受体信号和 BRD4,在慢性淋巴细胞白血病中显示出临床前活性。
Int J Mol Sci. 2022 Jun 16;23(12):6712. doi: 10.3390/ijms23126712.
4
Gene expression profile identifies distinct molecular subtypes and potential therapeutic genes in Merkel cell carcinoma.基因表达谱可识别默克尔细胞癌中不同的分子亚型和潜在治疗基因。
Transl Oncol. 2020 Nov;13(11):100816. doi: 10.1016/j.tranon.2020.100816. Epub 2020 Aug 6.
5
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment.InDePTH:抗癌药物治疗下用于构建基因表达网络的枢纽基因检测
Oncotarget. 2018 Jun 26;9(49):29097-29111. doi: 10.18632/oncotarget.25624.
6
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.弥漫性大 B 细胞淋巴瘤中外泌体为异常转录编程和基因组改变提供了丰富的线索。
Blood. 2018 Aug 16;132(7):e13-e23. doi: 10.1182/blood-2017-12-821843. Epub 2018 Jul 2.
7
Identification of IL-40, a Novel B Cell-Associated Cytokine.新型B细胞相关细胞因子IL-40的鉴定
J Immunol. 2017 Nov 1;199(9):3326-3335. doi: 10.4049/jimmunol.1700534. Epub 2017 Oct 4.
8
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.酪氨酸激酶抑制可增加 FLT3-ITD 的细胞表面定位,并增强急性髓系白血病的 FLT3 导向免疫治疗。
Leukemia. 2018 Feb;32(2):313-322. doi: 10.1038/leu.2017.257. Epub 2017 Aug 14.
9
Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.慢病毒载体转导的抗凋亡作用促进癌性B细胞对利妥昔单抗耐受性增加。
PLoS One. 2016 Apr 5;11(4):e0153069. doi: 10.1371/journal.pone.0153069. eCollection 2016.
10
Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.抑制溴结构域蛋白用于治疗人类弥漫性大B细胞淋巴瘤。
Clin Cancer Res. 2015 Jan 1;21(1):113-22. doi: 10.1158/1078-0432.CCR-13-3346. Epub 2014 Jul 9.